Sponsor Pipeline

RiboX Therapeutics Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-14 NCT07765966 Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06714253 Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 Radiation-Induced Xerostomia and Hyposalivation Recruiting
Phase 1
NCT07765966 Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias Relapsed or Refractory Autoimmune Cytopenias Not Yet Recruiting
Get alerts when RiboX Therapeutics Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free